Literature DB >> 27040958

Sickle Cell Disease in Sub-Saharan Africa.

Thomas N Williams1.   

Abstract

In Africa, at least 240,000 children are born each year with sickle cell disease. Historically, in the absence of newborn screening and appropriate treatment, most such children died undiagnosed in early childhood. However, with increasing awareness of the condition and economic and epidemiologic transition, increasing numbers are surviving. Greater investments in basic and applied research in the African context, and increased sensitization or African ministries of health regarding the importance of this condition, could make a substantial difference to the lives and livelihoods of millions of people living with sickle cell disease on the continent and their families.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteremia; Children; Public health; Sickle cell disease; Sub-Saharan Africa

Mesh:

Substances:

Year:  2016        PMID: 27040958      PMCID: PMC6858853          DOI: 10.1016/j.hoc.2015.11.005

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  91 in total

1.  Protective effects of the sickle cell gene against malaria morbidity and mortality.

Authors:  Michael Aidoo; Dianne J Terlouw; Margarette S Kolczak; Peter D McElroy; Feiko O ter Kuile; Simon Kariuki; Bernard L Nahlen; Altaf A Lal; Venkatachalam Udhayakumar
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

2.  Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.

Authors:  Najibah A Galadanci; Shehu U Abdullahi; Musa A Tabari; Shehi Abubakar; Raymond Belonwu; Auwal Salihu; Kathleen Neville; Fenella Kirkham; Baba Inusa; Yu Shyr; Sharon Phillips; Adetola A Kassim; Lori C Jordan; Muktar H Aliyu; Brittany V Covert; Michael R DeBaun
Journal:  Pediatr Blood Cancer       Date:  2014-11-14       Impact factor: 3.167

3.  [Prognosis of sickle cell anemia in Belgian Congo; based on 300 cases and 150 deaths].

Authors:  J LAMBOTTE-LEGRAND; C LAMBOTTEL-EGRAND
Journal:  Ann Soc Belg Med Trop (1920)       Date:  1955-02-28

4.  Variation in the pattern of bacterial infection in patients with sickle cell disease requiring admission.

Authors:  R M Akuse
Journal:  J Trop Pediatr       Date:  1996-12       Impact factor: 1.165

5.  Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.

Authors:  E P Vichinsky; L D Neumayr; A N Earles; R Williams; E T Lennette; D Dean; B Nickerson; E Orringer; V McKie; R Bellevue; C Daeschner; E A Manci
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

6.  Clinicopathologic characteristics of septicemia in sickle cell disease.

Authors:  J S Lobel; K E Bove
Journal:  Am J Dis Child       Date:  1982-06

7.  Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.

Authors:  Ofelia Alvarez; Nancy A Yovetich; J Paul Scott; William Owen; Scott T Miller; William Schultz; Alexandre Lockhart; Banu Aygun; Jonathan Flanagan; Melanie Bonner; Brigitta U Mueller; Russell E Ware
Journal:  Am J Hematol       Date:  2013-08-30       Impact factor: 10.047

8.  Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London.

Authors:  Paul Telfer; Pietro Coen; Subarna Chakravorty; Olu Wilkey; Jane Evans; Heather Newell; Beverley Smalling; Roger Amos; Adrian Stephens; David Rogers; Fenella Kirkham
Journal:  Haematologica       Date:  2007-07       Impact factor: 9.941

9.  Treatment for sickle cell disease in Africa: should we invest in haematopoietic stem cell transplantation?

Authors:  Gift Pule; Ambroise Wonkam
Journal:  Pan Afr Med J       Date:  2014-05-13

10.  The increased susceptibility of young red cells to invasion by the malarial parasite Plasmodium falciparum.

Authors:  G Pasvol; D J Weatherall; R J Wilson
Journal:  Br J Haematol       Date:  1980-06       Impact factor: 6.998

View more
  27 in total

1.  COVID-19 and Vulnerable Populations in Sub-Saharan Africa.

Authors:  J A George; M R Maphayi; T Pillay
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  What is the future of patient-reported outcomes in sickle-cell disease?

Authors:  Sharon A Singh; Nitya Bakshi; Prashant Mahajan; Claudia R Morris
Journal:  Expert Rev Hematol       Date:  2020-10-15       Impact factor: 2.929

3.  End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.

Authors:  Ann T Farrell; Julie Panepinto; Ankit A Desai; Adetola A Kassim; Jeffrey Lebensburger; Mark C Walters; Daniel E Bauer; Rae M Blaylark; Donna M DiMichele; Mark T Gladwin; Nancy S Green; Kathryn Hassell; Gregory J Kato; Elizabeth S Klings; Donald B Kohn; Lakshmanan Krishnamurti; Jane Little; Julie Makani; Punam Malik; Patrick T McGann; Caterina Minniti; Claudia R Morris; Isaac Odame; Patricia Ann Oneal; Rosanna Setse; Poornima Sharma; Shalini Shenoy
Journal:  Blood Adv       Date:  2019-12-10

4.  Paper-based microchip electrophoresis for point-of-care hemoglobin testing.

Authors:  Muhammad Noman Hasan; Arwa Fraiwan; Ran An; Yunus Alapan; Ryan Ung; Asya Akkus; Julia Z Xu; Amy J Rezac; Nicholas J Kocmich; Melissa S Creary; Tolulope Oginni; Grace Mfon Olanipekun; Fatimah Hassan-Hanga; Binta W Jibir; Safiya Gambo; Anil K Verma; Praveen K Bharti; Suchada Riolueang; Takdanai Ngimhung; Thidarat Suksangpleng; Priyaleela Thota; Greg Werner; Rajasubramaniam Shanmugam; Aparup Das; Vip Viprakasit; Connie M Piccone; Jane A Little; Stephen K Obaro; Umut A Gurkan
Journal:  Analyst       Date:  2020-03-03       Impact factor: 4.616

5.  Genetic modulation of anemia severity, hemolysis level, and hospitalization rate in Angolan children with Sickle Cell Anemia.

Authors:  Isabel Germano; Brígida Santos; Mariana Delgadinho; Catarina Ginete; Pedro Lopes; Ana Paula Arez; Miguel Brito; Paula Faustino
Journal:  Mol Biol Rep       Date:  2022-09-12       Impact factor: 2.742

6.  Economic burden of sickle cell disease in Brazil.

Authors:  Ana Cristina Silva-Pinto; Fernando F Costa; Sandra Fatima Menosi Gualandro; Patricia Belintani Blum Fonseca; Carmela Maggiuzzu Grindler; Homero C R Souza Filho; Carolina Tosin Bueno; Rodolfo D Cançado
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

7.  Xanthine Oxidase Drives Hemolysis and Vascular Malfunction in Sickle Cell Disease.

Authors:  Heidi M Schmidt; Katherine C Wood; Sara E Lewis; Scott A Hahn; Xena M Williams; Brenda McMahon; Jeffrey J Baust; Shuai Yuan; Timothy N Bachman; Yekai Wang; Joo-Yeun Oh; Samit Ghosh; Solomon F Ofori-Acquah; Jeffrey D Lebensburger; Rakesh P Patel; Jianhai Du; Dario A Vitturi; Eric E Kelley; Adam C Straub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-03       Impact factor: 8.311

8.  Genotypic Diversity among Angolan Children with Sickle Cell Anemia.

Authors:  Mariana Delgadinho; Catarina Ginete; Brígida Santos; Armandina Miranda; Miguel Brito
Journal:  Int J Environ Res Public Health       Date:  2021-05-19       Impact factor: 3.390

Review 9.  Sickle Cell Disease and the Respiratory System: A Tangential Perspective to the Hematopulmonological Dilemma.

Authors:  Ibrahim Sange; Phani Bhavana Cherukuri; Vaishnavi Parchuri; Natasha Srinivas; Sruthi Priyavadhana Ramanan; Aliya H Sange; Srimy Modi; Farhat A Khot
Journal:  Cureus       Date:  2021-06-10

10.  Stage-dependent fate of Plasmodium falciparum-infected red blood cells in the spleen and sickle-cell trait-related protection against malaria.

Authors:  Seidina A S Diakité; Papa Alioune Ndour; Valentine Brousse; Frederick Gay; Camille Roussel; Sylvestre Biligui; Michaël Dussiot; Virginie Prendki; Tatiana M Lopera-Mesa; Karim Traoré; Drissa Konaté; Saibou Doumbia; Jérôme Cros; Safi Dokmak; Rick M Fairhurst; Mahamadou Diakité; Pierre A Buffet
Journal:  Malar J       Date:  2016-09-21       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.